The MERLIN team met in Rotterdam 12 – 13 February 2015 to discuss progress in the first year of the project, and to make plans for the coming year. We’ve learned more about how MSC work in our in vitro and in vivo studies, and planning is well underway for the planned clinical trial with PSC patients. […]
Author Archive for: merlin_admin
This author has yet to write their bio.Meanwhile lets just say that we are proud merlin_admin contributed a whooping 52 entries.
Entries by merlin_admin
Steve Elliman of Orbsen Therapeutics has been interviewed by EuroStemCell – you can find videos of the interview by clicking here.
MERLIN has now been added to EuroStemCell’s Connections. EuroStemCell is a European partnership of scientists, clinicians, ethicists, social scientists and science communicators. Launched in March 2010, the partnership unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. http://www.eurostemcell.org/connections/merlin
MERLIN researcher Gideon Hirschfield of the University of Birmingham gave a talk about current and future therapies for PSC to patients. Watch a video of the presentation here.
MERLIN researcher Steve Elliman of Orbsen Therapeutics presented at the 8th Annual UK MSC meeting hosted by REMEDI in Galway 29 – 30 Oct, 2014. To read more about the conference, and to see a list of the other speakers, click here.
A new page dedicated to related publications has now gone live on the MERLIN site. This page can be accessed by following this link, and it will be updated throughout the project.
MERLIN recently received coverage on the Primary Sclerosing Cholangitis Support website. PSC Support is the UK charity dedicated to helping people affected by Primary Sclerosing Cholangitis (PSC). PSC Support is run by a small team of volunteers, totally funded from charitable donations, and here to help anyone affected by Primary Sclerosing Cholangitis. Our objectives are to: provide […]
Project Partner Orbsen Therapeutics presented at the ISCT Paris Conference on April 22nd 2014, in a session entitled “EU funded projects in Cell Therapy”.
The Irish Times covered the MERLIN Project on April 22nd, 2014, in an article titled “Orbsen Therapeutics to take part in €6m liver disease clinical trial.” Article Abstract: Orbsen Therapeutics, a spin-out from NUI Galway’s Regenerative Medicine Institute (Remedi) has announced plans to partner with the University of Birmingham in a €6 million project to […]
Article Link Here
- Cells cultured in vitro have the same biological characteristics as the functional cells that line the bile duct t.co/oFyJoVhH0A Time ago 7 Days via Twitter Web Client
- Here is an interesting new text from the leaders of the Stromal Immunology Group: t.co/8kupRloqoF @stromalimmune Time ago 8 Days via Twitter Web Client
- @PSCSupportUK wants to see a world without Primary Sclerosing Cholangitis. #PSC is a rare autoimmune disease of the… t.co/gEqQtgEbCP Time ago 12 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.